Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| RMI: Rivermead Mobility Index× | MDS-UPDRS× | |
|---|---|---|
| Campo | Neurologia | Neurologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1991 | 2008 |
| Ideatore≠ | Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre | Christopher G. Goetz and Movement Disorder Society |
| Tipo≠ | Clinician-observed performance test | Clinician-rated |
| Fonte seminale≠ | Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54. DOI ↗ | Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗ |
| Alias | Rivermead Mobility Index | UPDRS |
| Correlati | 5 | 5 |
| Sintesi≠ | The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes. | The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice. |
| ScholarGateInsieme di dati ↗ |
|
|